Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.

Yin ZM, Yu AJ, Wu MJ, Zhu JQ, Zhang X, Chen JH, Yuan SH, Yu H.

Eur J Gynaecol Oncol. 2014;35(3):259-63.

PMID:
24984537
2.

Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.

Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ.

Cancer. 2003 Feb 1;97(3):568-74.

3.
4.

Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.

Lee JM, Lee KB, Nam JH, Ryu SY, Bae DS, Park JT, Kim SC, Cha SD, Kim KR, Song SY, Kang SB.

Ann Oncol. 2008 Feb;19(2):321-6. Epub 2007 Oct 24.

PMID:
17962205
5.

Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.

Nagao S, Miwa M, Maeda N, Kogiku A, Yamamoto K, Morimoto A, Wakahashi S, Ichida K, Sudo T, Yamaguchi S, Sakuma T, Fujiwara K.

Int J Gynecol Cancer. 2015 Sep;25(7):1300-5. doi: 10.1097/IGC.0000000000000495.

PMID:
26166556
6.

[Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].

Wang Z, Wu L, Yao H, Sun Y, Li X, Li B, Zhang R, Ma S, Huang M.

Zhonghua Fu Chan Ke Za Zhi. 2015 Mar;50(3):198-203. Chinese.

PMID:
26268410
7.

A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.

Lee SW, Lim KT, Bae DS, Park SY, Kim YT, Kim KR, Nam JH.

Gynecol Obstet Invest. 2015;79(3):172-8. doi: 10.1159/000367920. Epub 2014 Dec 11.

PMID:
25500455
8.

Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.

Lan-Fang L, Hai-Yan S, Zuo-Ming Y, Jian-Qing Z, Ya-Qing C.

Eur J Gynaecol Oncol. 2012;33(1):68-73.

PMID:
22439409
9.

Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients.

Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, Osann K, Chan JK.

Am J Obstet Gynecol. 2010 Oct;203(4):347.e1-6. doi: 10.1016/j.ajog.2010.04.019. Epub 2010 Jul 1. Review.

PMID:
20579961
10.

Prognostic factors in definitive radiotherapy of uterine cervical cancer.

Yalman D, Aras AB, Ozkök S, Duransoy A, Celik OK, Ozsaran Z, Haydaroğlu A.

Eur J Gynaecol Oncol. 2003;24(3-4):309-14.

PMID:
12807246
11.
12.

Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.

Lee SW, Nam JH, Kim DY, Kim JH, Kim KR, Kim YM, Kim YT.

Int J Gynecol Cancer. 2010 Apr;20(3):411-6. doi: 10.1111/IGC.0b013e3181ce427b.

PMID:
20375806
13.

Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.

Yuan L, Jiang H, Lu Y, Guo SW, Liu X.

Int J Gynecol Cancer. 2015 Sep;25(7):1315-21. doi: 10.1097/IGC.0000000000000496.

PMID:
26186071
14.

[Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].

Qin JC, Li L, Yang ZJ, Yao DS, Li F, Zhang JQ.

Zhonghua Fu Chan Ke Za Zhi. 2011 May;46(5):360-3. Chinese.

PMID:
21733373
15.

Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.

Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd.

PMID:
23385284
16.

Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.

Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG.

Gynecol Oncol. 2009 Jun;113(3):316-23. doi: 10.1016/j.ygyno.2009.03.007. Epub 2009 Apr 5.

PMID:
19345400
17.

Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: a Taiwanese Gynecologic Oncology Group study.

Wang KL, Chang TC, Jung SM, Chen CH, Cheng YM, Wu HH, Liou WS, Hsu ST, Ou YC, Yeh LS, Lai HC, Huang CY, Chen TC, Chang CJ, Lai CH.

Eur J Cancer. 2012 Jul;48(10):1484-94. doi: 10.1016/j.ejca.2011.12.014. Epub 2012 Jan 13.

PMID:
22244826
18.

Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.

Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ.

Gynecol Oncol. 2004 Apr;93(1):27-33.

PMID:
15047210
19.

Enhanced efficacy of adjuvant chemotherapy and radiotherapy in selected cases of surgically resected neuroendocrine carcinoma of the uterine cervix: A retrospective cohort study.

Xie S, Song L, Yang F, Tang C, Yang S, He J, Pan X.

Medicine (Baltimore). 2017 Mar;96(11):e6361. doi: 10.1097/MD.0000000000006361.

20.

Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.

Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):780-93.

PMID:
12377330

Supplemental Content

Support Center